| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 3 | |
| #2 | Republic of Korea | 2 | |
| #3 | Brazil | 1 | |
| #4 | Canada | 1 | |
| #5 | China | 1 | |
| #6 | EPO (European Patent Office) | 1 | |
| #7 | Israel | 1 | |
| #8 | Mexico | 1 | |
| #9 | New Zealand | 1 | |
| #10 | Singapore | 1 | |
| #11 | WIPO (World Intellectual Property Organization) | 1 | |
| #12 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Heterocyclic compounds | |
| #3 | Therapeutic chemical compounds | |
| #4 | Organic chemistry methods |
| # | Name | Total Patents |
|---|---|---|
| #1 | Lee Edward | 9 |
| #2 | Frassetto Christa Leisa | 8 |
| #3 | Mcallister David | 8 |
| #4 | Trigwell Andrew | 8 |
| #5 | Snyder Peter Jr | 7 |
| #6 | Tuohy Iii Robert Vincent | 7 |
| #7 | Compere Delphine | 3 |
| #8 | Blumenfeld Marta | 3 |
| #9 | David Mcallister | 2 |
| #10 | Christa Leisa Frassetto | 2 |
| Publication | Filing date | Title |
|---|---|---|
| WO2017176777A1 | Bta-c585 for the treatment and/or prevention of conditions related to or associated with hyperuricemia or hyperuricosuria and other conditions | |
| MX2016017282A | Anhydrous crystalline free base form of-{2-[1-(6-methyl-3-pyridaz inyl)-4-piperidinyl]ethoxy}-3-ethoxy-1,2-benzisoxazole. |